| Feature Type | Standardized | Nominal ANOVA | ||||
|---|---|---|---|---|---|---|
| mRNA | FK866 | CTRPv2 | pan-cancer | AAC | 0.082 | 0.03 |
| mRNA | RAF265 | CTRPv2 | pan-cancer | AAC | -0.086 | 0.03 |
| mRNA | prima-1 | CTRPv2 | pan-cancer | AAC | 0.065 | 0.04 |
| mRNA | etoposide | CTRPv2 | pan-cancer | AAC | 0.061 | 0.04 |
| mRNA | Rapamycin | CTRPv2 | pan-cancer | AAC | 0.069 | 0.04 |
| mRNA | Erlotinib | CTRPv2 | pan-cancer | AAC | -0.069 | 0.05 |
| mRNA | 1S,3R-RSL-3 | CTRPv2 | pan-cancer | AAC | 0.066 | 0.05 |
| mRNA | CIL55A | CTRPv2 | pan-cancer | AAC | -0.1 | 0.05 |
| mRNA | myriocin | CTRPv2 | pan-cancer | AAC | -0.16 | 0.05 |
| mRNA | ML258 | CTRPv2 | pan-cancer | AAC | -0.074 | 0.05 |